A resolution relating to price disclosures of prescription drugs.

Summary

Declares that restraints on accurate prescription drug price disclosure are contrary to the public interest and that there is a need for a system of adequate price disclosure of prescription drugs. Expresses the sense of the Senate that the following practices are unfair trade practices within the meaning of the Federal Trade Commission Act: (1) restrictions on the disclosure by any retail seller of accurate price information regarding prescription drugs; (2) the failure of any retail seller to disclose adequate retail price information when requested of him; and (3) restrictions on the disclosure of adequate price information by any means of public communication.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 27 January 1976

   Introduced

   Referred to Senate Committee on Commerce.

   Source: IntroReferral

2. 27 January 1976

   Introduced

   Introduced in Senate

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Introduced in Senate

  summary · EN · 27 January 1976

  Open at official source

Sponsors

• Sen. Church, Frank [D-ID] · D · Sponsor
• Sen. Dole, Robert J. [R-KS] · R · Cosponsor
• Sen. Pell, Claiborne [D-RI] · D · Cosponsor
• Sen. Leahy, Patrick J. [D-VT] · D · Cosponsor
• Sen. Haskell, Floyd K. [D-CO] · D · Cosponsor
• Sen. Buckley, James L. [R-NY] · R · Cosponsor
• Sen. Abourezk, James [D-SD] · D · Cosponsor
• · sscm00 · Standing

Related records

No cross-record relationships stored yet.